Naftidrofuryl—a double blind cross-over study in the elderly

Smmary

A double-blind cross-over clinical trial of naftidrofuryl (‘Praxilene,’) is described in a group of 24 elderly subjects with severe intellectual impairment, using a simple psychometric test to assess mental function and behaviour. Significant improvement in intellectual function occurred with the drug and this effect was prolonged.

† ‘Praxilene’ is the trade mark of Lipha (U.K.)

Key Words::

• Psychoses
• senile
• psychometrics
• aged
• drug therapy
• cerebral arteriosclerosis

Notes

† ‘Praxilene’ is the trade mark of Lipha (U.K.)